These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 29422648)

  • 1. Unravelling the immune signature of Plasmodium falciparum transmission-reducing immunity.
    Stone WJR; Campo JJ; Ouédraogo AL; Meerstein-Kessel L; Morlais I; Da D; Cohuet A; Nsango S; Sutherland CJ; van de Vegte-Bolmer M; Siebelink-Stoter R; van Gemert GJ; Graumans W; Lanke K; Shandling AD; Pablo JV; Teng AA; Jones S; de Jong RM; Fabra-García A; Bradley J; Roeffen W; Lasonder E; Gremo G; Schwarzer E; Janse CJ; Singh SK; Theisen M; Felgner P; Marti M; Drakeley C; Sauerwein R; Bousema T; Jore MM
    Nat Commun; 2018 Feb; 9(1):558. PubMed ID: 29422648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Naturally acquired immune responses to Plasmodium falciparum sexual stage antigens Pfs48/45 and Pfs230 in an area of seasonal transmission.
    Ouédraogo AL; Roeffen W; Luty AJ; de Vlas SJ; Nebie I; Ilboudo-Sanogo E; Cuzin-Ouattara N; Teleen K; Tiono AB; Sirima SB; Verhave JP; Bousema T; Sauerwein R
    Infect Immun; 2011 Dec; 79(12):4957-64. PubMed ID: 21969000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The dynamics of naturally acquired immune responses to Plasmodium falciparum sexual stage antigens Pfs230 & Pfs48/45 in a low endemic area in Tanzania.
    Bousema T; Roeffen W; Meijerink H; Mwerinde H; Mwakalinga S; van Gemert GJ; van de Vegte-Bolmer M; Mosha F; Targett G; Riley EM; Sauerwein R; Drakeley C
    PLoS One; 2010 Nov; 5(11):e14114. PubMed ID: 21124765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naturally acquired antibody responses to recombinant Pfs230 and Pfs48/45 transmission blocking vaccine candidates.
    Jones S; Grignard L; Nebie I; Chilongola J; Dodoo D; Sauerwein R; Theisen M; Roeffen W; Singh SK; Singh RK; Singh S; Kyei-Baafour E; Tetteh K; Drakeley C; Bousema T
    J Infect; 2015 Jul; 71(1):117-27. PubMed ID: 25869538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune Responses to Gametocyte Antigens in a Malaria Endemic Population-The African
    Muthui MK; Kamau A; Bousema T; Blagborough AM; Bejon P; Kapulu MC
    Front Immunol; 2019; 10():2480. PubMed ID: 31695697
    [No Abstract]   [Full Text] [Related]  

  • 6. Transmission-reducing immunity is inversely related to age in Plasmodium falciparum gametocyte carriers.
    Drakeley CJ; Bousema JT; Akim NI; Teelen K; Roeffen W; Lensen AH; Bolmer M; Eling W; Sauerwein RW
    Parasite Immunol; 2006 May; 28(5):185-90. PubMed ID: 16629703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Naturally acquired immunity to sexual stage P. falciparum parasites.
    Stone WJ; Dantzler KW; Nilsson SK; Drakeley CJ; Marti M; Bousema T; Rijpma SR
    Parasitology; 2016 Feb; 143(2):187-98. PubMed ID: 26743529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extending the range of Plasmodium falciparum transmission blocking antibodies.
    Simons LM; Ferrer P; Gombakomba N; Underwood K; Herrera R; Narum DL; Canepa G; Acquah F; Amoah L; Duffy PE; Barillas-Mury C; Long C; Lee SM; Locke E; Miura K; Williamson KC
    Vaccine; 2023 May; 41(21):3367-3379. PubMed ID: 37100721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid onset of transmission-reducing antibodies in javanese migrants exposed to malaria in papua, indonesia.
    Bousema JT; Roeffen W; van der Kolk M; de Vlas SJ; van de Vegte-Bolmer M; Bangs MJ; Teelen K; Kurniawan L; Maguire JD; Baird JK; Sauerwein RW
    Am J Trop Med Hyg; 2006 Mar; 74(3):425-31. PubMed ID: 16525101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement-mediated lysis of Plasmodium falciparum gametes by malaria-immune human sera is associated with antibodies to the gamete surface antigen Pfs230.
    Healer J; McGuinness D; Hopcroft P; Haley S; Carter R; Riley E
    Infect Immun; 1997 Aug; 65(8):3017-23. PubMed ID: 9234748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modeling the impact of Plasmodium falciparum sexual stage immunity on the composition and dynamics of the human infectious reservoir for malaria in natural settings.
    Ouédraogo AL; Eckhoff PA; Luty AJF; Roeffen W; Sauerwein RW; Bousema T; Wenger EA
    PLoS Pathog; 2018 May; 14(5):e1007034. PubMed ID: 29742161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of heat-labile serum factor or host complement in the inhibition of Plasmodium falciparum sporogonic stages in Anopheles stephensi by gametocyte carriers' serological factors.
    Gouagna LC; van der Kolk M; Roeffen W; Verhave JP; Eling W; Sauerwein R; Boudin C
    Parasitology; 2007 Sep; 134(Pt 10):1315-27. PubMed ID: 17645813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potent transmission-blocking monoclonal antibodies from naturally exposed individuals target a conserved epitope on Plasmodium falciparum Pfs230.
    Ivanochko D; Fabra-García A; Teelen K; van de Vegte-Bolmer M; van Gemert GJ; Newton J; Semesi A; de Bruijni M; Bolscher J; Ramjith J; Szabat M; Vogt S; Kraft L; Duncan S; Lee SM; Kamya MR; Feeney ME; Jagannathan P; Greenhouse B; Sauerwein RW; Richter King C; MacGill RS; Bousema T; Jore MM; Julien JP
    Immunity; 2023 Feb; 56(2):420-432.e7. PubMed ID: 36792575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stage-specific Plasmodium falciparum immune responses in afebrile adults and children living in the Greater Accra Region of Ghana.
    Acquah FK; Lo AC; Akyea-Mensah K; Abagna HB; Faye B; Theisen M; Gyan BA; Amoah LE
    Malar J; 2020 Feb; 19(1):64. PubMed ID: 32041620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody responses to two new Lactococcus lactis-produced recombinant Pfs48/45 and Pfs230 proteins increase with age in malaria patients living in the Central Region of Ghana.
    Acquah FK; Obboh EK; Asare K; Boampong JN; Nuvor SV; Singh SK; Theisen M; Williamson KC; Amoah LE
    Malar J; 2017 Aug; 16(1):306. PubMed ID: 28764709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized feasibility trial comparing four antimalarial drug regimens to induce
    Reuling IJ; van de Schans LA; Coffeng LE; Lanke K; Meerstein-Kessel L; Graumans W; van Gemert GJ; Teelen K; Siebelink-Stoter R; van de Vegte-Bolmer M; de Mast Q; van der Ven AJ; Ivinson K; Hermsen CC; de Vlas S; Bradley J; Collins KA; Ockenhouse CF; McCarthy J; Sauerwein RW; Bousema T
    Elife; 2018 Feb; 7():. PubMed ID: 29482720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies elicited during natural infection in a predominantly Plasmodium falciparum transmission area cross-react with sexual stage-specific antigen in P. vivax.
    Bansal GP; Vengesai A; Cao Y; Mduluza T; Kumar N
    Acta Trop; 2017 Jun; 170():105-111. PubMed ID: 28257812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-Gametocyte Antigen Humoral Immunity and Gametocytemia During Treatment of Uncomplicated Falciparum Malaria: A Multi-National Study.
    O'Flaherty K; Chan JA; Cutts JC; Zaloumis SG; Ashley EA; Phyo AP; Drew DR; Dondorp AM; Day NP; Dhorda M; Fairhurst RM; Lim P; Amaratunga C; Pukrittayakamee S; Hien TT; Htut Y; Mayxay M; Faiz MA; Mokuolu OA; Onyamboko MA; Fanello C; Takashima E; Tsuboi T; Theisen M; Nosten F; Beeson JG; Simpson JA; White NJ; Fowkes FJI
    Front Cell Infect Microbiol; 2022; 12():804470. PubMed ID: 35463638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ELISA units, IgG subclass ratio and avidity determined functional activity of mouse anti-Pfs230 antibodies judged by a standard membrane-feeding assay with Plasmodium falciparum.
    Miura K; Deng B; Wu Y; Zhou L; Pham TP; Diouf A; Wu CK; Lee SM; Plieskatt JL; Morin MJ; Long CA
    Vaccine; 2019 Apr; 37(15):2073-2078. PubMed ID: 30850239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Highly potent, naturally acquired human monoclonal antibodies against Pfs48/45 block Plasmodium falciparum transmission to mosquitoes.
    Fabra-García A; Hailemariam S; de Jong RM; Janssen K; Teelen K; van de Vegte-Bolmer M; van Gemert GJ; Ivanochko D; Semesi A; McLeod B; Vos MW; de Bruijni MHC; Bolscher JM; Szabat M; Vogt S; Kraft L; Duncan S; Kamya MR; Feeney ME; Jagannathan P; Greenhouse B; Dechering KJ; Sauerwein RW; King CR; MacGill RS; Bousema T; Julien JP; Jore MM
    Immunity; 2023 Feb; 56(2):406-419.e7. PubMed ID: 36792574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.